Study To Examine Genotyping & Platelet Function Testing At Point-Of-Care To Personalize Anti-Platelet Therapy And …

A new study by the Center for Thrombosis Research at Sinai Hospital in Baltimore, MD will examine the utility of point-of-care genetic and platelet function testing to identify patients at risk for a cardiac event after coronary stenting. Therapy will be altered based on the testing results with the goal of improving patient outcomes. Under the direction of Paul A. Gurbel, MD, Director of the …